Puregraf 150 IU Injection

What is Puregraf 150 IU Injection?

Puregraf 150 IU Injection is a pharmaceutical preparation containing the active ingredient Menotrophin. Manufactured by Gufic Biosciences Ltd., this injectable medication is designed to support women experiencing fertility challenges. It plays a crucial role in stimulating the ovaries to promote egg development, assisting in the management of female infertility. Available for patients in Australia and other regions, Puregraf 150 IU Injection offers an evidence-based approach to fertility treatment under medical guidance.

Uses of Puregraf 150 IU Injection

Puregraf 150 IU Injection is primarily indicated for use in women diagnosed with infertility issues related to ovulatory dysfunction. It is prescribed when natural ovulation is impaired or absent, helping to induce the development of multiple follicles to facilitate conception. This medication is often employed in assisted reproductive treatments such as in vitro fertilization (IVF) or intrauterine insemination (IUI), enhancing the likelihood of successful pregnancy.

How Puregraf 150 IU Injection Works

Containing Menotrophin, Puregraf 150 IU mimics the action of naturally occurring follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones regulate the female reproductive cycle by stimulating the ovaries to produce multiple follicles, each potentially containing an egg. By providing controlled hormonal stimulation, the injection encourages ovarian follicle growth and maturation, improving ovulation chances.

Benefits of Puregraf 150 IU Injection

• Effective Ovulation Induction: Facilitates ovulation in women with hormonal imbalances or anovulation.
• Improved Fertility Outcomes: Increases the probability of conception when used in fertility treatments.
• Reliable Dosage Form: Provides a standardized Menotrophin dose ensuring consistent therapeutic effects.
• Professional Manufacturing: Developed by Gufic Biosciences Ltd., ensuring quality and safety.

Dosage and Administration

The dosage of Puregraf 150 IU Injection is individually tailored based on the patient's ovarian response and doctor's evaluation. Typically, the injection is administered intramuscularly or subcutaneously under medical supervision. Treatment cycles can vary in length, and ovarian monitoring through ultrasound and hormone levels often guides dose adjustments. Patients should strictly follow the prescribed regimen and never self-administer without proper training.

Available Strength

• Puregraf 75 IU Injection

Who Should Use Puregraf 150 IU Injection?

Puregraf 150 IU Injection is suitable for women diagnosed with infertility due to ovulatory disorders such as polycystic ovary syndrome (PCOS) or hypogonadotropic hypogonadism. It is also indicated for patients undergoing assisted reproductive technologies requiring controlled ovarian stimulation. The injection should only be used after a thorough consultation with a fertility specialist who has confirmed its appropriateness for the patient's condition.

Who Should Avoid Puregraf 150 IU Injection?

Puregraf 150 IU should not be used by women with primary ovarian failure, uncontrolled thyroid or adrenal dysfunction, or those who have abnormal uterine bleeding of undiagnosed origin. It is contraindicated in pregnant patients or women with a known hypersensitivity to Menotrophin or any formulation components. Patients should disclose their full medical history to their healthcare provider before starting treatment.

Possible Side Effects

While generally well tolerated, Puregraf 150 IU Injection can cause side effects in some patients. Common side effects include injection site reactions, mild abdominal discomfort, headache, and nausea. A rare but serious risk is ovarian hyperstimulation syndrome (OHSS), which requires immediate medical attention. Patients should promptly report severe pelvic pain, sudden weight gain, or breathing difficulties to their doctor.

Safety Advice

To maximize safety while using Puregraf 150 IU Injection, it is essential to follow all medical instructions carefully. Regular monitoring through ultrasounds and blood tests helps detect potential adverse reactions early. Patients should avoid self-medication and discuss any new medications or supplements with their healthcare provider. Pregnant or breastfeeding women should use this injection only if explicitly instructed by a specialist.

Drug Interactions

Puregraf 150 IU Injection may interact with other hormonal treatments or fertility medications. Inform your doctor about all current medicines, including over-the-counter drugs and herbal supplements. Careful management is necessary when combining medications that affect hormone levels to avoid unwanted side effects or reduced efficacy.

Storage Instructions

Store Puregraf 150 IU Injection in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect it from light and do not freeze. Keep the injection out of reach of children and store it in its original packaging until use. Always check the expiration date before administration and do not use the injection if it appears discolored or contains particles.

Where to buy Puregraf 150 IU Injection?

Puregraf 150 IU Injection can be purchased from licensed pharmacies ( kamagrajellyaustralia.com ) and authorized medical distributors across Australia. Patients should only buy this medication with a valid prescription from a qualified healthcare professional. Purchasing from reputable sources ensures product authenticity and safety.

Frequently Asked Questions (FAQ)

How long does it take for Puregraf 150 IU Injection to work?

The effects are usually observed within a couple of weeks as it stimulates follicle development during the ovarian cycle. Response time varies per patient and requires monitoring by a fertility specialist.

What should I do if Puregraf 150 IU Injection does not work?

If ovulation does not occur after an initial treatment cycle, consult your doctor. They may adjust the dose or explore alternative fertility treatments based on your individual response.

Can I take Puregraf 150 IU Injection with other medicines?

Inform your healthcare provider about all medications you are taking. Combining it with other hormonal therapies should be managed by a specialist to avoid interactions.

Is Puregraf 150 IU Injection safe for older adults?

Use in older adults should be under strict medical supervision, as ovarian reserve and response may vary. The prescribing doctor will evaluate suitability on a case-by-case basis.

What happens if I miss a dose of Puregraf 150 IU Injection?

Contact your healthcare provider immediately if you miss a dose. Do not self-administer the next dose without medical advice, as precise timing is important for treatment effectiveness.

Can side effects be prevented while using Puregraf 150 IU Injection?

While not all side effects can be prevented, following the prescribed dosage and attending regular monitoring visits helps minimize risks. Report any unusual symptoms to your doctor promptly.

When should I avoid using Puregraf 150 IU Injection?

Avoid use if you are pregnant, have ovarian cysts, unexplained vaginal bleeding, or known allergies to its components. Always consult your physician before starting treatment.

Conclusion

Puregraf 150 IU Injection is a vital fertility treatment option containing Menotrophin, aimed at aiding women in overcoming ovulatory infertility challenges. Manufactured by Gufic Biosciences Ltd., it offers effective and reliable hormonal stimulation under careful medical supervision. With proper use, monitoring, and consultation, Puregraf 150 IU Injection can significantly contribute to achieving successful pregnancy outcomes in women facing fertility difficulties in Australia and worldwide.